DOTANOC and DOTATATE PET-CT — A Scan Built for Neuroendocrine Tumours

Both are Gallium-68 somatostatin receptor tracers that detect the same group of conditions. The technical difference is receptor binding: DOTATATE has very high affinity for one subtype, SSTR2, while DOTANOC binds three subtypes — SSTR2, SSTR3, and SSTR5. In practice, the choice is made by your oncologist based on your tumour type and referral; it is not something you decide. At CION partner imaging centres, both scans are available subject to tracer supply, which is confirmed at the time of booking.

Not automatically. Gallium-68 tracers have a short half-life and are produced in small batches. Supply is confirmed at the time of booking — your scan date is set only once that confirmation is in place. Last-minute changes do happen if a batch is delayed. If you are travelling from outside the city specifically for this scan, ask the team to confirm explicitly that tracer supply is secured before you make travel or accommodation arrangements.

Preparation for somatostatin receptor PET is different from FDG PET. FDG PET requires strict fasting because blood sugar affects tracer uptake. That constraint does not apply in the same way here, but preparation requirements can still vary depending on your specific situation and whether other tests are being done at the same visit. Ask the imaging centre at the time of booking and follow their instructions exactly — do not assume the same rules apply as for any FDG scan you may have had before.

The tracer is given as a small intravenous injection. You then wait for it to distribute through the body before the scan begins — this waiting period is typically around one hour. The scan itself takes less than an hour in most cases. Total time at the centre, including waiting, is usually two to three hours. You can eat and drink normally during the waiting period unless the team tells you otherwise. The imaging team will confirm the exact timeline at booking.

DOTANOC and DOTATATE PET-CT are coordinated through CION partner imaging centres at an indicative cost of around ₹23,999 as of mid-2026 — confirm the current figure at the time of booking, as costs change. Whether your health insurer covers it depends on your specific policy. Coverage for Gallium-68 nuclear medicine imaging varies widely. When you contact your insurer, ask about Gallium-68 somatostatin receptor PET-CT by that full name rather than PET-CT in general — policies often list procedures by their technical designation.

Directly, yes. Peptide Receptor Radionuclide Therapy (PRRT) is a treatment for neuroendocrine tumours that uses the same somatostatin receptor system to deliver targeted radiation to tumour cells. Before PRRT can be considered, your team needs to confirm that your tumour shows adequate somatostatin receptor uptake on a Gallium-68 PET scan. A DOTANOC or DOTATATE PET is required as part of the PRRT workup, and the result directly affects whether that treatment is an option for you.